Kimberly Clark (KMB) Holding Held by Windward Capital Management Company; As Accelerate Diagnostics (AXDX) Stock Price Declined, Shareholder Trellus Management Company Has Trimmed by $533,208 Its Position

May 23, 2018 - By wolcottdaily

Kimberly-Clark Corporation (NYSE:KMB) Logo

Adam Usdan decreased its stake in Accelerate Diagnostics Inc (AXDX) by 70.27% based on its latest 2017Q4 regulatory filing with the SEC. Trellus Management Company Llc sold 20,508 shares as the company’s stock declined 17.34% with the market. The hedge fund run by Adam Usdan held 8,678 shares of the capital goods company at the end of 2017Q4, valued at $227,000, down from 29,186 at the end of the previous reported quarter. Trellus Management Company Llc who had been investing in Accelerate Diagnostics Inc for a number of months, seems to be less bullish one the $1.13B market cap company. The stock decreased 1.87% or $0.4 during the last trading session, reaching $21. About 86,405 shares traded. Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has declined 0.88% since May 23, 2017 and is downtrending. It has underperformed by 12.43% the S&P500.

Windward Capital Management Company increased its stake in Kimberly Clark Corp (KMB) by 92.34% based on its latest 2017Q4 regulatory filing with the SEC. Windward Capital Management Company bought 5,930 shares as the company’s stock declined 10.91% with the market. The institutional investor held 12,352 shares of the containers and packaging company at the end of 2017Q4, valued at $1.49M, up from 6,422 at the end of the previous reported quarter. Windward Capital Management Company who had been investing in Kimberly Clark Corp for a number of months, seems to be bullish on the $36.48 billion market cap company. The stock decreased 0.34% or $0.36 during the last trading session, reaching $104.42. About 1.10M shares traded. Kimberly-Clark Corporation (NYSE:KMB) has declined 18.78% since May 23, 2017 and is downtrending. It has underperformed by 30.33% the S&P500.

More news for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) were recently published by: Nasdaq.com, which released: “Accelerate Diagnostics to Review First Quarter 2018 Results on May 9th” on April 30, 2018. Nasdaq.com‘s article titled: “Report: Developing Opportunities within US Ecology, Universal Health Realty Income Trust, Accelerate Diagnostics …” and published on May 04, 2018 is yet another important article.

Analysts await Accelerate Diagnostics, Inc. (NASDAQ:AXDX) to report earnings on August, 2. They expect $-0.37 EPS, down 19.35% or $0.06 from last year’s $-0.31 per share. After $-0.37 actual EPS reported by Accelerate Diagnostics, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Since February 20, 2018, it had 7 insider buys, and 0 selling transactions for $4.73 million activity.

Among 4 analysts covering Accelerate Diagnostics (NASDAQ:AXDX), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Accelerate Diagnostics had 9 analyst reports since August 25, 2015 according to SRatingsIntel. On Thursday, March 24 the stock rating was initiated by JP Morgan with “Overweight”. Piper Jaffray maintained it with “Buy” rating and $32.0 target in Sunday, September 17 report. The rating was reinitiated by BTIG Research on Wednesday, July 12 with “Buy”. Piper Jaffray maintained the stock with “Buy” rating in Thursday, August 3 report. William Blair initiated the stock with “Outperform” rating in Friday, January 8 report. The company was upgraded on Tuesday, August 25 by BTIG Research. The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) earned “Overweight” rating by JP Morgan on Tuesday, August 9. Piper Jaffray initiated the stock with “Overweight” rating in Wednesday, December 16 report. The firm has “Neutral” rating by BTIG Research given on Wednesday, December 13.

Investors sentiment decreased to 0.81 in Q4 2017. Its down 0.82, from 1.63 in 2017Q3. It fall, as 21 investors sold AXDX shares while 32 reduced holdings. 15 funds opened positions while 28 raised stakes. 19.90 million shares or 6.66% less from 21.32 million shares in 2017Q3 were reported. Blair William Communications Il has invested 0.18% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Miura Mngmt invested 2.28% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Amer Int Gru Incorporated owns 17,551 shares. Nuveen Asset Mngmt Ltd Com reported 0.11% stake. Moreover, First Republic Invest Management has 0.11% invested in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Principal Fincl Group Inc owns 8,294 shares. Moreover, Selkirk Mgmt Limited Com has 5.06% invested in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 361,550 shares. Gsa Cap Prtn Limited Liability Partnership has invested 0.04% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Royal Financial Bank Of Canada owns 3,168 shares for 0% of their portfolio. Artal Grp holds 0.2% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 500,000 shares. Capital Fincl Advisers Limited Liability holds 0% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 13,296 shares. 1,750 are held by Zurcher Kantonalbank (Zurich Cantonalbank). Aqr Cap Ltd Liability reported 7,739 shares. Hightower Advsrs Limited Liability Com reported 0% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Obermeyer Wood Inv Counsel Lllp holds 0.49% or 214,427 shares in its portfolio.

Trellus Management Company Llc, which manages about $123.52M and $73.30 million US Long portfolio, upped its stake in Spdr S&P 500 Etf Tr (Put) (SPY) by 20,000 shares to 50,000 shares, valued at $13.34 million in 2017Q4, according to the filing. It also increased its holding in National Oilwell Varco Inc (NYSE:NOV) by 10,000 shares in the quarter, for a total of 20,000 shares, and has risen its stake in Health Ins Innovations Inc (NASDAQ:HIIQ).

Since January 29, 2018, it had 1 buying transaction, and 1 insider sale for $2.57 million activity. DECHERD ROBERT W bought $200,100 worth of Kimberly-Clark Corporation (NYSE:KMB) on Tuesday, April 24.

More news for Kimberly-Clark Corporation (NYSE:KMB) were recently published by: Seekingalpha.com, which released: “Dividend Income Update April 2018” on May 13, 2018. Seekingalpha.com‘s article titled: “Trade War Relief Rally – Cramer’s Mad Money (5/21/18)” and published on May 22, 2018 is yet another important article.

Investors sentiment decreased to 0.93 in Q4 2017. Its down 0.03, from 0.96 in 2017Q3. It fall, as 72 investors sold KMB shares while 404 reduced holdings. 99 funds opened positions while 344 raised stakes. 252.01 million shares or 2.69% more from 245.40 million shares in 2017Q3 were reported. Tocqueville Asset Management LP holds 0.09% or 62,850 shares. Bellecapital Interest owns 1,780 shares for 0.17% of their portfolio. Carroll Assocs accumulated 0.05% or 3,655 shares. Hancock Hldgs Co has 11,710 shares for 0.06% of their portfolio. Bollard Llc holds 0.15% or 26,352 shares. Hartford Fin Mgmt has invested 1.37% in Kimberly-Clark Corporation (NYSE:KMB). Oppenheimer & Company reported 29,670 shares or 0.09% of all its holdings. Hilltop reported 8,489 shares stake. Plante Moran Fincl Advisors Lc owns 2,581 shares. Kbc Nv invested 0.11% of its portfolio in Kimberly-Clark Corporation (NYSE:KMB). Pension Ser invested 0.19% of its portfolio in Kimberly-Clark Corporation (NYSE:KMB). Supplemental Annuity Collective Of Nj holds 6,134 shares or 0.31% of its portfolio. Wallington Asset Management Limited Liability Corp holds 1.75% or 56,335 shares in its portfolio. Evermay Wealth Management Limited Liability owns 1,715 shares or 0.08% of their US portfolio. Moreover, Essex Fin Ser has 0.24% invested in Kimberly-Clark Corporation (NYSE:KMB).

Kimberly-Clark Corporation (NYSE:KMB) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>